Conclusion For patients experiencing weight regain after bariatric surgery, two-thirds of the weight regain can be safely lost with GLP1-RA, providing clinicians with a therapeutic option for this clinical challenge, and highlights the need for a large-scale randomized clinical trial
95% CI 0.222.01) did not show this association if the patients did not have gastrointestinal (GI) symptoms during this time (Santos et al
Expecting a single drug to meaningfully alter the course of Alzheimers once cognitive decline is underway is an extraordinarily high bar. However, Kaeberlein believed there may still be hope
Product quality & formulation accuracy matter more than dose escalation
[DOI] [PubMed] [Google Scholar] 128.Grau T., Bonet A., Miambres E., Pieiro L., Irles J.A., Robles A., Acosta J., Herrero I., Palacios V., Lopez J., et al